Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 30, 2019 - Issue 2
Submit an article Journal homepage
427
Views
18
CrossRef citations to date
0
Altmetric
Psoriasis and dermatitis

Pediatric patients with psoriasis and psychiatric disorders: premorbidity and comorbidity in a case-control study

Tayfun KaraDepartment of Child and Adolescent Psychiatry, University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-2156-3457
ORCID Icon,
Zeynep TopkarcıDepartment of Dermatology, University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey; ORCID Iconhttp://orcid.org/0000-0002-3847-0695
ORCID Icon,
Semra YılmazDepartment of Child and Adolescent Psychiatry, University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey; ORCID Iconhttp://orcid.org/0000-0002-6527-2432
ORCID Icon,
İsmail AkaltunDepartment of Child and Adolescent Psychiatry, Gaziantep Dr. Ersin Arslan Training and Research Hospital, Gaziantep, TurkeyORCID Iconhttp://orcid.org/0000-0002-9938-9276
ORCID Icon &
Bilgen ErdoğanDepartment of Dermatology, University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey; ORCID Iconhttp://orcid.org/0000-0002-7956-5869
ORCID Icon
Pages 129-134 | Received 19 Apr 2018, Accepted 07 May 2018, Published online: 28 May 2018

References

  • Matterne U, Apfelbacher C. Peer-relationship-problems account for quality of life impairments in pediatric psoriasis. J Psychosom Res. 2016;84:31–36.
  • Osier E, Wang AS, Tollefson MM, et al. Pediatric Psoriasis Comorbidity Screening Guidelines. JAMA Dermatol. 2017;153:698–704.
  • Busch AL, Landau JM, Moody MN, et al. Pediatric psoriasis. Skin Therapy Lett. 2012;17:5–7.
  • de Moll EH, Chang MW, Strober B. Psoriasis in adults and children: kids are not just little people. Clin Dermatol. 2016;34:717–723.
  • Dogra S, Mahajan R. Psoriasis: epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J. 2016;7:471–480.
  • Seyhan M, Coşkun BK, Sağlam H, et al. Psoriasis in childhood and adolescence: evaluation of demographic and clinical features. Pediatr Int. 2006;48:525–530.
  • Bilgiç Ö, Bilgiç A, Sivrikaya A, et al. Association between endocrinological, immunological and psychosocial variables in psoriasis patients. G Ital Dermatol Venereol. 2016;151:603–609.
  • Kumar S, Kachhawha D, Das Koolwal G, et al. Psychiatric morbidity in psoriasis patients: a pilot study. Indian J Dermatol Venereol Leprol. 2011;77:625.
  • Jafferany M, Franca K. Psychodermatology: basics concepts. Acta Derm Venereol. 2016;96:35–37.
  • Lønnberg AS, Skov L. Co-morbidity in psoriasis: mechanisms and implications for treatment. Expert Rev Clin Immunol. 2017;13:27–34.
  • Olsen JR, Gallacher J, Finlay AY, et al. Quality of life impact of childhood skin conditions measured using the Children’s Dermatology Life Quality Index (CDLQI): a meta-analysis. Br J Dermatol. 2016;174:853–861.
  • Relvas M, Torres T. Pediatric psoriasis. Am J Clin Dermatol. 2017;18:797–811.
  • Gökler B, Ünal F, Pehlivantürk B, et al. Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-Turkish version (K-SADS-PL-T). Turk J Child Adolesc Mental Health. 2004;11:109–116.
  • Balcı DD, Sangün Ö, İnandı T. Cross validation of the Turkish version of Children’s Dermatology Life Quality Index. J Turk Acad Dermatol. 2007;1:71402a.
  • Karaceylan F. Reliability and validity of SCARED in Turkish children. [dissertation]. Kocaeli: Kocaeli University; 2005.
  • Öy B. Children’s Depression Inventory: a study of reliability and validity. Turk. Anadolu Psikiyatri Derg. 1991;2:132–136.
  • Kuhn H, Mennella C, Magid M, et al. Psychocutaneous disease: pharmacotherapy and psychotherapy. J Am Acad Dermatol. 2017;76:795–808.
  • Kwon HH, Na SJ, Jo SJ, et al. Epidemiology and clinical features of pediatric psoriasis in tertiary referral psoriasis clinic. J Dermatol. 2012;39:260–264.
  • Mercy K, Kwasny M, Cordoro KM, et al. Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States. Pediatr Dermatol. 2013;30:424–428.
  • Manzoni AP, Pereira RL, Townsend RZ, et al. Assessment of the quality of life of pediatric patients with the major chronic childhood skin diseases. An Bras Dermatol. 2012;87:361–368.
  • Ozden MG, Tekin NS, Gürer MA, et al. Environmental risk factors in pediatric psoriasis: a multicenter case-control study. Pediatr Dermatol. 2011;28:306–312.
  • Burden-Teh E, Thomas KS, Ratib S, et al. The epidemiology of childhood psoriasis: a scoping review. Br J Dermatol. 2016;174:1242–1257.
  • Tangtatco JAA, Lara-Corrales I. Update in the management of pediatric psoriasis. Curr Opin Pediatr. 2017;29:434–442.
  • Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000;17:174–178.
  • Gupta MA, Guptat AK. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol. 2001;15:512–518.
  • Kumar B, Jain R, Sandhu K, et al. Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int J Dermatol. 2004;43:654–658.
  • Kimball AB, Wu EQ, Guérin A, et al. Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol. 2012;67:651–657.
  • Wu JJ, Feldman SR, Koo J, et al. Epidemiology of mental health comorbidity in psoriasis. J Dermatolog Treat. 2017. [cited 2017 Nov 10]:[1–9 p.]. DOI:10.1080/09546634.2017.1395800
  • Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol. 2004;45:155–159.
  • Bilgic A, Bilgic Ö, Akış HK, et al. Psychiatric symptoms and health-related quality of life in children and adolescents with psoriasis. Pediatr Dermatol. 2010;27:614–617.
  • Hon KL, Pong NH, Poon TC, et al. Quality of life and psychosocial issues are important outcome measures in eczema treatment. J Dermatolog Treat. 2015;26:83–89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.